BIOMAT Database Logo BIOMAT Database Logo

Mepacrine, a phospholipase inhibitor. 1987

J Seguin, and P Berta, and M Saussine, and P A Chaptal

UI MeSH Term Description Entries
D010740 Phospholipases A class of enzymes that catalyze the hydrolysis of phosphoglycerides or glycerophosphatidates. EC 3.1.-. Lecithinases,Lecithinase,Phospholipase
D011796 Quinacrine An acridine derivative formerly widely used as an antimalarial but superseded by chloroquine in recent years. It has also been used as an anthelmintic and in the treatment of giardiasis and malignant effusions. It is used in cell biological experiments as an inhibitor of phospholipase A2. Mepacrine,Acrichine,Atabrine,Atebrin,Quinacrine Dihydrochloride,Quinacrine Dihydrochloride, Dihydrate,Quinacrine Dihyrochloride, (R)-Isomer,Quinacrine Dihyrochloride, (S)-Isomer,Quinacrine Dimesylate,Quinacrine Hydrochloride,Quinacrine Monoacetate,Quinacrine Monohydrochloride,Quinacrine Monomesylate,Quinacrine, (+-)-Isomer,Quinacrine, (R)-Isomer,Quinacrine, (S)-Isomer,Dihydrochloride, Quinacrine,Dimesylate, Quinacrine,Hydrochloride, Quinacrine,Monoacetate, Quinacrine,Monohydrochloride, Quinacrine,Monomesylate, Quinacrine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

J Seguin, and P Berta, and M Saussine, and P A Chaptal
Mepacrine, a phospholipase inhibitor. A potential tool for modifying myocardial reperfusion injury.
August 1986, The Journal of thoracic and cardiovascular surgery,
J Seguin, and P Berta, and M Saussine, and P A Chaptal
Inhibition of complement-mediated hepatic thromboxane production by mepacrine, a phospholipase inhibitor.
February 1987, Prostaglandins,
J Seguin, and P Berta, and M Saussine, and P A Chaptal
Mechanism of suppression of cardiac L-type Ca(2+) currents by the phospholipase A(2) inhibitor mepacrine.
July 2000, European journal of pharmacology,
J Seguin, and P Berta, and M Saussine, and P A Chaptal
Effects of the phospholipase inhibitor mepacrine on injury in ischemic and metabolically inhibited adult isolated myocytes.
March 1991, The American journal of pathology,
J Seguin, and P Berta, and M Saussine, and P A Chaptal
Ca2+-antagonistic properties of phospholipase A2 inhibitors, mepacrine and chloroquine.
April 1989, General physiology and biophysics,
J Seguin, and P Berta, and M Saussine, and P A Chaptal
Stimulation of polymorphonuclear leucocyte phospholipase A2 activity by chloroquine and mepacrine.
November 1982, The Journal of pharmacy and pharmacology,
J Seguin, and P Berta, and M Saussine, and P A Chaptal
The effect of phospholipase inhibitor mepacrine on platelet aggregation, the platelet release reaction and fibrinogen binding to the platelet surface.
June 1981, Thrombosis and haemostasis,
J Seguin, and P Berta, and M Saussine, and P A Chaptal
Studies on phospholipase A inhibitor in blood plasma. II. Interaction of phospholipase A inhibitor with phospholipase A and its specificity.
July 1985, Journal of biochemistry,
J Seguin, and P Berta, and M Saussine, and P A Chaptal
[Phospholipase A2 inhibitor].
April 2000, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme,
J Seguin, and P Berta, and M Saussine, and P A Chaptal
[Phospholipase C inhibitor].
September 1997, Gan to kagaku ryoho. Cancer & chemotherapy,
Copied contents to your clipboard!